Perrigo and Flamel sign OTC drug delivery deal

8 October 2015 - Deborah Wilkes

Archived

Perrigo plans to develop a portfolio of extended-release oral suspension products for the US OTC market using Flamel's LiquiTime technology.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: